Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 23.96% is 687% above its 5-year average of -4.08%, near the high end of its 5-year range (-82.42%–64.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 199.92% above its 12-month average of 7.99%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 23.96%.
RETURN ON EQUITY (ROE)
23.96%
RETURN ON EQUITY (ROE) AVG TTM
7.99%
RETURN ON EQUITY (ROE) AVG 3Y
-19.70%
RETURN ON EQUITY (ROE) AVG 5Y
-4.08%
RETURN ON EQUITY (ROE) AVG 10Y
-8.04%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+199.92%
CURRENT VS 3Y AVG
+221.64%
CURRENT VS 5Y AVG
+687.01%
CURRENT VS 10Y AVG
+398.10%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
+159.60%
vs the sector median at left
The Joint Corp.
Market Cap
$101.21M
Return on Equity (ROE)
23.96%
TTM Avg
7.99%
3Y Avg
-19.70%
5Y Avg
-4.08%
Market Cap
$98.16M
Return on Equity (ROE)
-72.02%
TTM Avg
-67.42%
3Y Avg
-55.49%
5Y Avg
-62.36%
Market Cap
$104.67M
Return on Equity (ROE)
-116.28%
TTM Avg
-71.19%
3Y Avg
-41.66%
5Y Avg
-29.50%
Market Cap
$106.99M
Return on Equity (ROE)
-99.67%
TTM Avg
-40.73%
3Y Avg
98.81%
5Y Avg
13.93%
Market Cap
$95.95M
Return on Equity (ROE)
-461.14%
TTM Avg
-233.39%
3Y Avg
-227.67%
5Y Avg
-163.94%
Market Cap
$106.56M
Return on Equity (ROE)
-87.45%
TTM Avg
455.42%
3Y Avg
120.34%
5Y Avg
63.42%
Market Cap
$106.51M
Return on Equity (ROE)
-44.29%
TTM Avg
-31.86%
3Y Avg
-53.29%
5Y Avg
-49.85%
Market Cap
$107.43M
Return on Equity (ROE)
-60.82%
TTM Avg
-19.88%
3Y Avg
-19.08%
5Y Avg
-15.27%
Market Cap
$94.76M
Return on Equity (ROE)
-103.31%
TTM Avg
-140.03%
3Y Avg
-67.31%
5Y Avg
-49.97%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $101.21M | 23.96% | 7.99% | -19.70% | -4.08% |
| Anixa Biosciences, Inc. (ANIX)vs › | $98.16M | -72.02% | -67.42% | -55.49% | -62.36% |
| Definitive Healthcare Corp. (DH)vs › | $104.67M | -116.28% | -71.19% | -41.66% | -29.50% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.99M | -99.67% | -40.73% | 98.81% | 13.93% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.95M | -461.14% | -233.39% | -227.67% | -163.94% |
| Immunic, Inc. (IMUX)vs › | $106.56M | -87.45% | 455.42% | 120.34% | 63.42% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $106.51M | -44.29% | -31.86% | -53.29% | -49.85% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.43M | -60.82% | -19.88% | -19.08% | -15.27% |
| Korro Bio, Inc. (KRRO)vs › | $94.76M | -103.31% | -140.03% | -67.31% | -49.97% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -80.97% | -121.11% | -93.50% | -70.15% |
ROE
24.0%
ROA
7.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 23.96% |
| 2026-03-31 | 20.94% |
| 2025-12-31 | 19.31% |
| 2025-09-30 | -3.52% |
| 2025-06-30 | -20.74% |
| 2025-03-31 | -42.73% |
| 2024-12-31 | -41.30% |
| 2024-09-30 | -82.42% |
| 2024-06-30 | -62.14% |
| 2024-03-31 | -42.52% |
| 2023-12-31 | -39.41% |
| 2023-09-30 | 5.21% |
| 2023-06-30 | 9.26% |
| 2023-03-31 | 7.79% |
| 2022-12-31 | 1.26% |
| 2022-09-30 | -1.58% |
| 2022-06-30 | 2.33% |
| 2022-03-31 | 14.36% |
| 2021-12-31 | 21.71% |
| 2021-09-30 | 60.48% |
| 2021-06-30 | 64.01% |
| 2021-03-31 | 62.91% |
| 2020-12-31 | 62.33% |
| 2020-09-30 | 40.61% |
| 2020-06-30 | 37.85% |
| 2020-03-31 | 46.02% |
| 2019-12-31 | 58.10% |
| 2019-09-30 | 75.36% |
| 2019-06-30 | 76.76% |
| 2019-03-31 | 76.85% |
| 2018-12-31 | 10.72% |
| 2018-09-30 | -59.54% |
| 2018-06-30 | -77.81% |
| 2018-03-31 | -190.37% |
| 2017-12-31 | -66.86% |
| 2017-09-30 | -187.98% |
| 2017-06-30 | -241.29% |
| 2017-03-31 | -242.20% |
| 2016-12-31 | -219.10% |
| 2016-09-30 | -104.35% |
| 2016-06-30 | -80.36% |
| 2016-03-31 | -60.04% |
| 2015-12-31 | -42.54% |
| 2015-09-30 | -73.53% |
| 2015-06-30 | -53.71% |
| 2015-03-31 | -34.69% |
| 2014-12-31 | -19.40% |
